Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy.
about
Development of Hematopoietic Stem Cell Based Gene Therapy for HIV-1 Infection: Considerations for Proof of Concept Studies and Translation to Standard Medical PracticeCD25 preselective anti-HIV vectors for improved HIV gene therapy.Optimized lentiviral vectors for HIV gene therapy: multiplexed expression of small RNAs and inclusion of MGMT(P140K) drug resistance geneAssociation of thymidylate synthase polymorphisms with acute pancreatitis and/or peripheral neuropathy in HIV-infected patients on stavudine-based therapyPolymorphisms of Pyrimidine Pathway Enzymes Encoding Genes and HLA-B*40∶01 Carriage in Stavudine-Associated Lipodystrophy in HIV-Infected Patients.Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular studyIncreased inflammation but similar physical composition and function in older-aged, HIV-1 infected subjects.Dysregulation of Endoplasmic Reticulum Stress and Autophagic Responses by the Antiretroviral Drug Efavirenz.Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17.Activation and lysis of human CD4 cells latently infected with HIV-1Lipolytic Rate Associated With Intramyocardial Lipid in an HIV Cohort Without Increased Lipolysis.HIV-related stigma and physical symptoms have a persistent influence on health-related quality of life in Australians with HIV infection.Novel forms of lipodystrophy: why should we care?Changes in abdominal fat following antiretroviral therapy initiation in HIV-infected individuals correlate with waist circumference and self-reported changes.Highly active antiretroviral therapy dysregulates proliferation and differentiation of human pre-adipocytes.AIDS Clinical Research in Spain-Large HIV Population, Geniality of Doctors, and Missing Opportunities.
P2860
Q29036869-6EAA6E6D-F242-4182-9421-83FF75123B39Q33586299-DDC6FE6F-08B7-4823-BEE7-5CE65AEED394Q33586969-67B96692-2EB6-43FD-9FBF-B454AEF74E57Q34612023-923E983C-1914-4DBF-837C-F49E5B7022E0Q34806335-F3D9A26E-14A2-4A64-9576-B1E877E815D4Q35106654-84E69AA2-A6F1-437F-AFAF-C76E68BE66B9Q35708716-539513B0-81B2-4A92-8F79-BE6FE00D947DQ35897840-20165DDD-DAD7-4F2A-8951-B0C281965E56Q36226553-B7EF9728-E5D7-402B-BBBC-92CE28CDF399Q36250921-73871730-9ADD-43B2-B8DE-AB2ACBF06B16Q36431659-CFAD0BC6-2194-4866-8920-6A9855C652BAQ36759011-0AEEE885-E5B4-4BFD-9F30-17CD973923EFQ37022579-D6F908F1-60E5-4ADB-ABC1-616B34EF1764Q38936060-C65D8FD0-341F-4036-97B1-7B8836387FA8Q41450474-A4FFE6DC-AC21-44FC-A845-5613B3C011C3Q55698444-1008AE0B-DEB9-4801-82F3-C068B72A8DA5
P2860
Fat redistribution syndromes associated with HIV-1 infection and combination antiretroviral therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Fat redistribution syndromes a ...... nation antiretroviral therapy.
@en
type
label
Fat redistribution syndromes a ...... nation antiretroviral therapy.
@en
prefLabel
Fat redistribution syndromes a ...... nation antiretroviral therapy.
@en
P2093
P1433
P1476
Fat redistribution syndromes a ...... ination antiretroviral therapy
@en
P2093
Esteban Martínez
Francesc Villaroya
José López-Aldeguer
Pere Domingo
P304
P577
2012-04-01T00:00:00Z